CompleWare and Vida Announce Joint Marketing Agreement for Respiratory Trials

October 5, 2017 — CompleWare and Vida recently announced a joint marketing agreement promoting complementary respiratory services. Their partnership will deploy a high-end pulmonary platform and excellence in clinical trial management, with precision, ISO-certified core lab imaging. 

CompleWare software and contract research organization (CRO) services will facilitate complete respiratory development programs. This will provide specialized experts to support global respiratory trials. VIDA and CompleWare will provide precision lung imaging informatics, delivered through core lab imaging services (Precision Services) and interactive software (VIDA|vision). This solution spans the care cycle, from detection through treatment across a range of pulmonary diseases: COPD (including severe emphysema, chronic bronchitis), lung cancer and asthma.

The CompleClinical application from CompleWare is a comprehensive eClinical solution for clinical trial data capture and management. The VIDA|vision pulmonary suite of software and services provides full breadth and depth of analysis, empowering chest physicians with advanced, quantitative information to help inform care decisions. 

For more information: www.compleware.com, www.vidadiagnostics.com